OpenNeedle Ask your own

Question explored with the scientific record

Potassium supplements

Sep 12, 2026 · 8 sources used · OpenNeedle synthesis
Potassium supplements are not a casual health hack. They are a medical intervention for specific, documented deficiencies.

The evidence here shows potassium works as a real treatment when you actually need it. A pregnant woman with severe hyperemesis and a potassium level of 2.0 mEq/L developed rhabdomyolysis and kidney problems, and oral potassium chloride brought her back to normal [1]. A child who got bentonite clay (which binds potassium) dropped to 0.9 mEq/L and needed emergency potassium to survive [2]. These are clear rescue scenarios.

The blood pressure data is real but modest. A 12-week trial in Chinese adults with mild hypertension found potassium supplements (60 mmol/day) lowered systolic pressure by about 5 mmHg more than placebo [4]. Another trial in people at moderate cardiovascular risk found a similar 5.3 mmHg drop in brachial systolic pressure [6]. But the effect is not universal. One double-blind trial in mild hypertension found the blood pressure drop lost statistical significance after adjusting for baseline differences [3]. And the same trial that showed a blood pressure drop also found that potassium increased plasma renin activity and aldosterone [6], which is the body pushing back against the change.

There is a real risk here that nobody talks about. In a study of heart failure patients, having serum potassium outside the middle range was linked to much higher risk of cardiovascular events. The hazard ratios were 3.56 for low potassium and 4.04 for high potassium compared to the middle quartile [5]. That is a U-shaped curve. Too little is bad, too much is worse. The safe range is narrow.

The bone density data is interesting but comes from a single trial using potassium citrate, not potassium chloride [7]. That trial found a 1.7% increase in lumbar spine bone density over 24 months. But the study was funded by a manufacturer of potassium citrate products, and the effect was on a surrogate endpoint, not on actual fracture rates.

The bottom line: potassium supplements help people with documented deficiency or high blood pressure on a high-sodium diet, but the benefit is modest and the risk of pushing potassium too high is real and dangerous.

My call: do not take potassium supplements without a blood test showing you are low. If you have hypertension, try getting potassium from food first. If you are on a thiazide diuretic, the evidence suggests potassium loss drives the diabetes risk from that drug [8], so monitoring is essential. Confidence: moderate. The blood pressure trials are decent but small, the safety data on hyperkalemia is thin, and the long-term effects on hard outcomes like heart attack or death have not been studied in a randomized trial.

Keep digging

Sources used 8

  1. Hyperemesis gravidarum followed by refeeding syndrome causes electrolyte abnormalities induced rhabdomyolysis and diabetes insipidus Endocrine Journal (2019) Thin

    A 34-year-old pregnant woman with severe hyperemesis gravidarum developed refeeding syndrome–related electrolyte disturbances (hypophosphatemia and hypokalemia) that triggered rhabdomyolysis and nephrogenic diabetes insipidus, which resolved after oral potassium chloride therapy…

    DOI: 10.1507/endocrj.EJ18-0496
  2. Severe Hypokalemia Caused by Oral and Rectal Administration of Bentonite in a Pediatric Patient Pediatric Emergency Care (2006) primary study Strong

    Oral and rectal administration of bentonite caused severe hypokalemia in a pediatric patient.

    DOI: 10.1097/01.pec.0000227873.05119.e6
  3. Double-blind, placebo-controlled trial of potassium chloride in the treatment of mild hypertension. Hypertension (1987) Thin

    This study investigates the antihypertensive effects of potassium chloride supplementation in adults with mild hypertension through a randomized, double-blind, placebo-controlled trial, finding a significant reduction in systolic and diastolic blood pressure in the potassium gro…

    DOI: 10.1161/01.hyp.9.5.444
  4. Effect of potassium supplementation on blood pressure in Chinese: a randomized, placebo-controlled trial Journal of Hypertension (2001) Thin

    In Beijing, China, a 12-week, randomized, double-blind, placebo-controlled trial showed that daily potassium supplementation (60 mmol) reduced systolic blood pressure by about 5 mmHg in adults with mild hypertension/high-normal BP on a high-sodium diet, with no significant effec…

    DOI: 10.1097/00004872-200107000-00019
  5. A4799 The Cardio-cerebral Vascular Risk in elderly hypertensives with orthostatic hypotension Journal of Hypertension (2018) Thin

    This e132 Journal of Hypertension supplement compiles several observational studies on morning blood pressure variability, seasonal and regional BP patterns, ambulatory BP metrics, and potassium-related prognostic signals in HFpEF and elderly hypertensive cohorts, highlighting p…

    DOI: 10.1097/01.hjh.0000548530.39896.5b
  6. A randomised controlled trial evaluating the effect of potassium supplementation on vascular function and the renin–angiotensin–aldosterone system Journal of Human Hypertension (2013) Thin

    Potassium supplementation (64 mmol/day) in adults at moderate cardiovascular risk reduced brachial and central blood pressure but did not improve vascular function, while increasing plasma renin activity and aldosterone in a 6-week randomized cross-over trial.

    DOI: 10.1038/jhh.2013.89
  7. Effect of Potassium Citrate on Bone Density, Microarchitecture, and Fracture Risk in Healthy Older Adults without Osteoporosis: A Randomized Controlled Trial The Journal of Clinical Endocrinology & Metabolism (2013) Thin

    Potassium citrate supplementation increases lumbar spine areal bone mineral density and improves trabecular bone microarchitecture in healthy older adults without osteoporosis, while reducing FRAX-predicted fracture risk over 24 months.

    DOI: meta/10.1210/jc.2012-3099
  8. Changes in Serum Potassium Mediate Thiazide-Induced Diabetes Hypertension (2008) Thin

    This study reanalyzes the SHEP trial data to show that thiazide-induced diabetes in older adults is driven by early declines in serum potassium, with potassium changes mediating the increased diabetes risk and suggesting potassium supplementation as a potential preventive strate…

    DOI: 10.1161/hypertensionaha.108.119438

Your question next

What do you want to know?

No question is too uncomfortable for the evidence. Bring yours.

Ask your question